CD8A and melanoma: The Vx-001 includes two hTERT peptides that are presented on the MHC I complexes of antigen-presenting cells, causing the killing of cholangiocarcinoma, non-small cell lung cancer, melanoma, and breast cancer cells by cytotoxic CD8+ T lymphocytes [242].